Substitution of methionine 63 or 83 in S100A9 and cysteine 42 in S100A8 abrogate the antifungal activities of S100A8/A9: potential role for oxidative regulation: RESEARCH ARTICLE

Herve Y. Sroussi, Gerwald A. Köhler, Nina Agabian, Dana Villines, Joel M. Palefsky

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

S100A8 and S100A9 and their heterocomplex calprotectin (S100A8/A9) are abundant cytosolic constituents in human neutrophils previously shown to possess antifungal activity. This study was designed to investigate mechanisms involved in the modulation of the antifungal properties of S100A8/A9. S100A8, S100A9 and site-directed mutants of both proteins were tested for their antifungal effect against Candida albicans in microplate dilution assays. Whereas S100A8 alone did not inhibit fungal growth, S100A9 by itself had a moderate antifungal effect. Combining both proteins had the strongest effect. Supporting a potential role for oxidation in S100A8/A9, substitution of methionine 63 or 83 of S100A9 resulted in the loss of antifungal activity. Additionally, the substitution to alanine of cysteine 42 of S100A8 also caused a loss of S100A8's ability to enhance S100A9's antifungal effect. Overall, our data indicate that both S100A8 and S100A9 are required for their fully active antifungal effect and that oxidation regulates S100A8/A9 antifungal activity through mechanisms that remain to be elucidated and evaluated. Finally, together with our previous work describing the oxidation-sensitive anti-inflammatory effects of S100A8/A9, we propose that S100A8/A9 exerts an anti-inflammatory activity in healthy state and that conditions associated with oxidative stress activate the antifungal activity of S100A8/A9.

Original languageEnglish
Pages (from-to)55-61
Number of pages7
JournalFEMS Immunology and Medical Microbiology
Volume55
Issue number1
DOIs
StatePublished - 1 Jan 2009

Fingerprint

Methionine
Cysteine
Anti-Inflammatory Agents
Leukocyte L1 Antigen Complex
Mutant Proteins
Candida albicans
Alanine
Oxidative Stress
Neutrophils
Growth
Proteins

Keywords

  • Antifungal
  • Calprotectin
  • Candida albicans
  • Oxidation
  • S100A8
  • S100A9

Cite this

@article{7a9895ce84004979aeca12a645e8750b,
title = "Substitution of methionine 63 or 83 in S100A9 and cysteine 42 in S100A8 abrogate the antifungal activities of S100A8/A9: potential role for oxidative regulation: RESEARCH ARTICLE",
abstract = "S100A8 and S100A9 and their heterocomplex calprotectin (S100A8/A9) are abundant cytosolic constituents in human neutrophils previously shown to possess antifungal activity. This study was designed to investigate mechanisms involved in the modulation of the antifungal properties of S100A8/A9. S100A8, S100A9 and site-directed mutants of both proteins were tested for their antifungal effect against Candida albicans in microplate dilution assays. Whereas S100A8 alone did not inhibit fungal growth, S100A9 by itself had a moderate antifungal effect. Combining both proteins had the strongest effect. Supporting a potential role for oxidation in S100A8/A9, substitution of methionine 63 or 83 of S100A9 resulted in the loss of antifungal activity. Additionally, the substitution to alanine of cysteine 42 of S100A8 also caused a loss of S100A8's ability to enhance S100A9's antifungal effect. Overall, our data indicate that both S100A8 and S100A9 are required for their fully active antifungal effect and that oxidation regulates S100A8/A9 antifungal activity through mechanisms that remain to be elucidated and evaluated. Finally, together with our previous work describing the oxidation-sensitive anti-inflammatory effects of S100A8/A9, we propose that S100A8/A9 exerts an anti-inflammatory activity in healthy state and that conditions associated with oxidative stress activate the antifungal activity of S100A8/A9.",
keywords = "Antifungal, Calprotectin, Candida albicans, Oxidation, S100A8, S100A9",
author = "Sroussi, {Herve Y.} and K{\"o}hler, {Gerwald A.} and Nina Agabian and Dana Villines and Palefsky, {Joel M.}",
year = "2009",
month = "1",
day = "1",
doi = "10.1111/j.1574-695X.2008.00498.x",
language = "English",
volume = "55",
pages = "55--61",
journal = "FEMS Immunology and Medical Microbiology",
issn = "0928-8244",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "1",

}

Substitution of methionine 63 or 83 in S100A9 and cysteine 42 in S100A8 abrogate the antifungal activities of S100A8/A9 : potential role for oxidative regulation: RESEARCH ARTICLE. / Sroussi, Herve Y.; Köhler, Gerwald A.; Agabian, Nina; Villines, Dana; Palefsky, Joel M.

In: FEMS Immunology and Medical Microbiology, Vol. 55, No. 1, 01.01.2009, p. 55-61.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Substitution of methionine 63 or 83 in S100A9 and cysteine 42 in S100A8 abrogate the antifungal activities of S100A8/A9

T2 - potential role for oxidative regulation: RESEARCH ARTICLE

AU - Sroussi, Herve Y.

AU - Köhler, Gerwald A.

AU - Agabian, Nina

AU - Villines, Dana

AU - Palefsky, Joel M.

PY - 2009/1/1

Y1 - 2009/1/1

N2 - S100A8 and S100A9 and their heterocomplex calprotectin (S100A8/A9) are abundant cytosolic constituents in human neutrophils previously shown to possess antifungal activity. This study was designed to investigate mechanisms involved in the modulation of the antifungal properties of S100A8/A9. S100A8, S100A9 and site-directed mutants of both proteins were tested for their antifungal effect against Candida albicans in microplate dilution assays. Whereas S100A8 alone did not inhibit fungal growth, S100A9 by itself had a moderate antifungal effect. Combining both proteins had the strongest effect. Supporting a potential role for oxidation in S100A8/A9, substitution of methionine 63 or 83 of S100A9 resulted in the loss of antifungal activity. Additionally, the substitution to alanine of cysteine 42 of S100A8 also caused a loss of S100A8's ability to enhance S100A9's antifungal effect. Overall, our data indicate that both S100A8 and S100A9 are required for their fully active antifungal effect and that oxidation regulates S100A8/A9 antifungal activity through mechanisms that remain to be elucidated and evaluated. Finally, together with our previous work describing the oxidation-sensitive anti-inflammatory effects of S100A8/A9, we propose that S100A8/A9 exerts an anti-inflammatory activity in healthy state and that conditions associated with oxidative stress activate the antifungal activity of S100A8/A9.

AB - S100A8 and S100A9 and their heterocomplex calprotectin (S100A8/A9) are abundant cytosolic constituents in human neutrophils previously shown to possess antifungal activity. This study was designed to investigate mechanisms involved in the modulation of the antifungal properties of S100A8/A9. S100A8, S100A9 and site-directed mutants of both proteins were tested for their antifungal effect against Candida albicans in microplate dilution assays. Whereas S100A8 alone did not inhibit fungal growth, S100A9 by itself had a moderate antifungal effect. Combining both proteins had the strongest effect. Supporting a potential role for oxidation in S100A8/A9, substitution of methionine 63 or 83 of S100A9 resulted in the loss of antifungal activity. Additionally, the substitution to alanine of cysteine 42 of S100A8 also caused a loss of S100A8's ability to enhance S100A9's antifungal effect. Overall, our data indicate that both S100A8 and S100A9 are required for their fully active antifungal effect and that oxidation regulates S100A8/A9 antifungal activity through mechanisms that remain to be elucidated and evaluated. Finally, together with our previous work describing the oxidation-sensitive anti-inflammatory effects of S100A8/A9, we propose that S100A8/A9 exerts an anti-inflammatory activity in healthy state and that conditions associated with oxidative stress activate the antifungal activity of S100A8/A9.

KW - Antifungal

KW - Calprotectin

KW - Candida albicans

KW - Oxidation

KW - S100A8

KW - S100A9

UR - http://www.scopus.com/inward/record.url?scp=58149295902&partnerID=8YFLogxK

U2 - 10.1111/j.1574-695X.2008.00498.x

DO - 10.1111/j.1574-695X.2008.00498.x

M3 - Article

C2 - 19087201

AN - SCOPUS:58149295902

VL - 55

SP - 55

EP - 61

JO - FEMS Immunology and Medical Microbiology

JF - FEMS Immunology and Medical Microbiology

SN - 0928-8244

IS - 1

ER -